Related Experiment Video

Updated: Jun 10, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Epidermal growth factor receptor as a target for anti-cancer agent design

Jiangying Cao1, Hao Fang, Binghe Wang

  • 1Department of Medicinal Chemistry, Shandong University, Jinan, PR China.

Anti-Cancer Agents in Medicinal Chemistry
|August 12, 2010
PubMed

Insights

Epidermal growth factor (EGF) receptors are key targets in cancer therapy. This review covers recent advances in understanding EGF receptor structures, functions, and the development of targeted inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Epidermal growth factor (EGF) receptors are a family of protein tyrosine kinases (PTKs).
  • These receptors play a crucial role in cell growth and are implicated in various cancers.
  • Targeting EGF receptors presents a promising strategy for cancer treatment.

Purpose of the Study:

  • To review recent advancements in the structural and functional understanding of EGF receptor tyrosine kinases.
  • To summarize the development and therapeutic potential of various EGF receptor inhibitors.
  • To provide an overview of FDA-approved and clinically investigated EGF receptor-targeted therapies.

Main Methods:

  • Literature review of scientific publications on EGF receptors and their inhibitors.
  • Analysis of structural and functional data of EGF receptor tyrosine kinases.
  • Compilation of information on different classes of EGF receptor inhibitors, including monoclonal antibodies (mAbs), reversible, and irreversible inhibitors.

Main Results:

  • Significant progress has been made in elucidating the structures and functions of EGF receptors.
  • A diverse range of inhibitors, including mAbs and small molecules, have been developed.
  • Several EGF receptor inhibitors are currently undergoing clinical trials or have received FDA approval.

Conclusions:

  • EGF receptor tyrosine kinases remain critical targets for novel cancer therapies.
  • The development of specific inhibitors has led to improved treatment options for cancer patients.
  • Continued research into EGF receptor biology and inhibitor development holds promise for future cancer treatment strategies.

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.